Is excitation-contraction coupling impaired in myasthenia gravis?

Clinical Neurophysiology

Volumn 118, Issue 5, 2007, Pages 1144-1148

  Nakata, Miho ^a   Kuwabara, Satoshi ^a   Kawaguchi, Naoki ^a   Takahashi, Hirokatsu ^a   Misawa, Sonoko ^a   Kanai, Kazuaki ^a   Tamura, Noriko ^a   Sawai, Setsu ^a   Motomura, Masakatsu ^b   Shiraishi, Hirokazu ^b   Takamori, Masaharu ^c   Maruta, Takahiro ^d   Yoshikawa, Hiroaki ^d   Hattori, Takamichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Kanazawa Nishi Hospital   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Excitation contraction coupling; FK506; Myasthenia gravis; Ryanodine receptor

Indexed keywords

CALCIUM ION; CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID; ENZYME ANTIBODY; PROTEIN TYROSINE KINASE; RECEPTOR ANTIBODY; RYANODINE RECEPTOR; TACROLIMUS;

ACCELEROMETER; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTRONEUROLOGY; EXCITATION CONTRACTION COUPLING; FEMALE; FINGER; HAND MOVEMENT; HAND MUSCLE; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MUSCLE ACTION POTENTIAL; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THUMB; THYMOMA;

ACTION POTENTIALS; ADULT; AGED; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTERCOSTAL MUSCLES; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACROLIMUS; THYMOMA; THYMUS NEOPLASMS;

EID: 34047093978     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2007.01.001     Document Type: Article

References (28)

1. Aarli J.A., Stefansson K., Marton L.S.G., and Wollmann R.L. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 82 (1990) 284-288
2. Aarli J.A., Skeie G.O., Mygland Å., and Gilhus N.E. Muscle striation antibodies in myasthenia gravis: diagnostic and functional significance. Ann NY Acad Sci 841 (1998) 505-516
3. Drachman D.B., Adams R.N., Stanley E.F., and Pestronk A. Mechanisms of acetylcholine receptor loss in myasthenia gravis. J Neurol Neurosurg Psychiatry 43 (1980) 601-610
4. Franzini-Armstrong C., and Nunzi G. Junctional feet and particles in the triads of a fast-twitch muscle fibre. J Muscle Res Cell Motil 4 (1983) 233-252
5. Iwasa K., Komai K., and Takamori M. Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies. Muscle Nerve 21 (1998) 1655-1660
6. Jaretzki A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 55 (2000) 16-23
7. Krarup C. Electrical and mechanical responses in the platysma and in the adductor pollicis muscle: in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry 40 (1977) 241-249
8. Leong P., and MacLennan D.H. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. J Biol Chem 273 (1998) 7791-7794
9. Leong P., and MacLennan D.H. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor. J Biol Chem 273 (1998) 29958-29964
10. Lindstrom J.M., Seybold M.E., Lennon V.A., Whittingham S., and Duane D.D. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 26 (1976) 1054-1059
11. Mygland Å., Tysnes O.B., Matre R., Volpe P., Aarli J.A., and Gilhus N.E. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol 32 (1992) 589-591
12. Nemoto Y., Kuwabara S., Misawa S., Kawaguchi N., Hattori T., Takamori M., et al. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 76 (2005) 714-718
13. Ohta M., Ohta K., Itoh N., Kurobe M., Hayashi K., and Nishitani H. Anti-skeletal muscle antibodies in the sera from myasthenic patients with thymoma: identification of anti-myosin, actomyosin, actin, and α-actinin antibodies by a solid-phase radioimmunoassay and a Western blotting analysis. Clin Chim Acta 187 (1990) 255-264
14. Oosterhuis H., and Bethlem J. Neurogenic muscle involvement in myasthenia gravis: a clinical and histopathological study. J Neurol Neurosurg Psychiatry 36 (1973) 244-254
15. Oosterhuis H., Limburg P.C., Hummel-Tappel E., and The T.H. Anti-acetylcholine receptor antibodies in myasthenia gravis: clinical and serological follow-up of individual patients. J Neurol Sci 58 (1983) 371-385
16. Pagala M.K.D., Nandakumar N.V., Venkatachari S.A.T., Ravindran K., Namba T., and Grob D. Responses of intercostal muscle biopsies form normal subjects and patients with myasthenia gravis. Muscle Nerve 13 (1990) 1012-1022
17. Pagala M.K.D., Nandakumar N.V., Venkatachari S.A.T., Ravindran K., Amaladevi B., Namba T., et al. Mechanisms of fatigue in normal intercostal muscle and muscle form patients with myasthenia gravis. Muscle Nerve 16 (1993) 911-921
18. Penn A.S., Schotland D.L., and Lamme S. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis. Muscle Nerve 9 (1986) 407-415
19. Shiraishi H., Motomura M., Yoshimura T., Fukudome T., Fukuda T., Nakao Y., et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 57 (2005) 289-293
20. Slomić A., Rosenfalck A., and Buchthal F. Electrical and mechanical responses of normal and myasthenic muscle: with particular reference to the staircase phonimenon. Brain Res 10 (1968) 1-78
21. Somnier F.E., and Trojaborg W. Neurophysiological evaluation in myasthenia gravis: a comprehensive study of a complete patient population. Electroencephalogr Clin Neurophysiol 89 (1993) 73-87
22. Somnier F.E., Skeie G.O., Aarli J.A., and Trojaborg W. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. Eur J Neurol 6 (1999) 555-563
23. Strauss A.J.L., van der Geld H.W.R., Kemp P.G., Exum E.D., and Goodman H.C. Immunological concomitants of myasthenia gravis. Ann NY Acad Sci 124 (1965) 744-766
24. Takamori M., Motomura M., Kawaguchi N., Nemoto Y., Hattori T., Yoshikawa H., et al. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis. Neurology 62 (2004) 1894-1896
25. Tanabe T., Beam K.G., Adams B.A., Niidome T., and Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 346 (1990) 567-569
26. Timerman A.P., Ogunbumni E., Freund E., Wiederrecht G., Marks A.R., and Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein: dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem 268 (1993) 22992-22999
27. Vincent A., and Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 48 (1985) 1246-1252
28. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 265 (1990) 2244-2256